AnaptysBio Inc sell JPMorgan Chase & Co.
Start price
13.04.23
/
50%
€19.70
Target price
13.04.24
€28.05
Performance (%)
1.02%
End price
14.04.24
€19.90
Summary
This prediction ended on 14.04.24 with a price of €19.90. The SELL prediction by JPMorgan_Chase___Co_ shows the price for AnaptysBio Inc slightly increased by 1.02% during the runtime of the prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AnaptysBio Inc | -1.939% | -1.939% | 103.214% | 195.584% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % | 53,46 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % | 72,28 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % | 63,08 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % | 60,40 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $31.00. They now have an "underweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten